![Christine Silverstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Silverstein
Finanzdirektor/CFO bei
Artios Pharma Ltd.
Vermögen: 691 068 $ am 31.05.2026
Profil
Christine Berni Silverstein is currently Chief Financial Officer at Artios Pharma Ltd. since 2024.
Christine is also a member of the National Investor Relations Institute, Women in Bio, Inc., and Project 1972, Inc. Former roles include Managing Director at SCO Financial Group LLC; Director-Investor Relations at Relmada Therapeutics, Inc. from 2014 to 2016; Independent Director at Immedica Pharma US, Inc. from 2023 to 2025; Independent Director at Abeona Therapeutics, Inc. from 2020 to 2026; Chief Financial Officer at Excision BioTherapeutics, Inc. from 2021 to 2024; and Chief Financial Officer at Emendo Biotherapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Peter J.
Tobin College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 119’562 ( 0.21% ) | 691 068 $ | 31.05.2026 |
Aktive Positionen von Christine Silverstein
| Unternehmen | Position | Beginn |
|---|---|---|
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Corporate Officer/Principal | - |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Corporate Officer/Principal | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Finanzdirektor/CFO | 01.02.2024 |
Ehemalige bekannte Positionen von Christine Silverstein
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Finanzdirektor/CFO | 31.03.2020 |
| MARINUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.02.2025 |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Finanzdirektor/CFO | 01.01.2024 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Finanzdirektor/CFO | 01.01.2021 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Kontakt | 01.01.2016 |
Ausbildung von Christine Silverstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Commercial Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Peter J. Tobin College of Business
 Peter J. Tobin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
Wählen Sie MarketScreener 
